RECORDATI AG
RECORDATI AG is a Originators company based in Basel (Basel-Stadt) recorded by Swissmedic as the authorisation holder for 29 human medicines. That places it 61 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Basel |
| Canton | Basel-Stadt |
| Authorisation holder | Yes |
| Medicines | 29 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | Recordati S.p.A. |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
RECORDATI AG is recorded by Swissmedic as the authorisation holder for 29 human medicines. The table shows 29 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
29 of 29 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Aethoxysklerol 0.5 % | 33273 | B | C05BB02 | 1967-10-02 |
| Beloc i.v. | 56191 | B | C07AB02 | 2003-06-06 |
| Beloc Zok 50 mg | 52110 | B | C07AB02 | 1993-02-25 |
| Calperos D3 | 54822 | D | A12AX | 1999-04-12 |
| Carbaglu 200 mg | 67376 | B | A16AA05 | 2020-07-28 |
| CitraFleet | 65202 | B | A06AB58 | 2014-04-09 |
| Cystadrops 3.8 mg/ml | 67380 | B | S01XA21 | 2020-09-24 |
| Eligard 22.5 mg | 56892 | A | L02AE02 | 2004-12-29 |
| Eligard 45 mg | 58431 | A | L02AE02 | 2008-01-31 |
| Eligard 7.5 mg | 56852 | A | L02AE02 | 2004-12-29 |
| Enjaymo 1100 mg/22 ml | 68074 | A | L04AJ04 | 2023-06-21 |
| Isturisa 1 mg | 67262 | A | H02CA02 | 2020-10-12 |
| Lacdigest | 53055 | D | A09AA04 | 1998-06-10 |
| Ledaga | 67615 | A | L01AA05 | 2021-09-28 |
| Livazo 1 mg | 62329 | B | C10AA08 | 2012-07-17 |
| Logimax 10/100 mg | 52238 | B | C07FB02 | 1993-08-26 |
| Normosang | 52776 | A | B06AB01 | 1995-02-09 |
| Orthoton 750 mg | 68326 | B | - | 2023-07-20 |
| Reagila 1.5 mg | 66364 | B | N05AX15 | 2018-06-19 |
| Signifor 0.3 mg/1 ml | 61254 | B | H01CB05 | 2012-11-02 |
| Signifor LAR 20 mg | 65148 | A | H01CB05 | 2015-02-25 |
| Sulfarlem S 25 | 37234 | D | A16AX02 | 1973-07-19 |
| Tretinac 10 mg | 55873 | A | D10BA01 | 2002-11-05 |
| Urispas | 58644 | B | G04BD02 | 2008-08-08 |
| UROCIT | 61884 | B | G04BC | 2012-06-21 |
| Urorec 4 mg | 65513 | B | G04CA04 | 2016-06-09 |
| Vazkepa 998 mg | 68354 | B | C10AX06 | 2022-11-22 |
| Zanidip 10 mg | 54874 | B | C08CA13 | 2004-09-28 |
| Zanipress 10 mg/10 mg | 59192 | B | C09BB02 | 2009-08-18 |
Frequently asked questions
How many medicines does RECORDATI AG have authorised in Switzerland?
RECORDATI AG is recorded by Swissmedic as the authorisation holder for 29 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is RECORDATI AG based?
The Swiss location recorded for RECORDATI AG is Basel, Basel-Stadt.
Is RECORDATI AG a Swissmedic authorisation holder?
Yes. RECORDATI AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.